Key statistics
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | -- |
Average volume | -- |
---|---|
Shares outstanding | 5.32bn |
Free float | 5.13bn |
P/E (TTM) | -- |
Market cap | 21.28m AUD |
EPS (TTM) | -0.0052 AUD |
Data delayed at least 15 minutes.
More ▼
Announcements
- Alterity Therapeutics Raises Profile with Multiple Data Presentations at the International Congress of Parkinson’s Disease and Movement Disorders®
- Alterity Therapeutics Appoints Abby Macnish Niven as Chief Financial Officer
- Alterity Therapeutics to Deliver Multiple Oral and Poster Presentations at the International Congress of Parkinson’s Disease and Movement Disorders®
- Appendix 4C – Q4 FY24 Quarterly Cash Flow Report
- Alterity Therapeutics to Present at MST Financial Webinar
- Alterity Therapeutics Reports Positive Interim Data from ATH434-202 Phase 2 Clinical Trial in Multiple System Atrophy
- Alterity Therapeutics Reports Positive Interim Data from ATH434-202 Phase 2 Clinical Trial in Multiple System Atrophy
- Alterity Therapeutics to Present at the MST Access ‘Hidden Gems in Life Sciences’ Webinar
- Alterity Therapeutics to Host Webcast Today on New Data from the bioMUSE Natural History Study
- Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Planned After Third Review
More ▼